StonvexLoading…
StonvexStonvexStonvexCore line items from FF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $95.74M | $243.34M | $368.25M | $116.75M |
Operating Income | $-52.99M | $6.37M | $27.37M | Not available |
Net Income | $-49.40M | $15.50M | $37.38M | $2.78M |
EPS (Diluted) | $-1.13 | $0.35 | $0.85 | $0.06 |
Total Assets | $192.24M | $247.69M | $367.08M | Not available |
Total Liabilities | $37.53M | $41.87M | $57.20M | Not available |
Cash & Equivalents | $51.32M | $109.54M | $219.44M | Not available |
Free Cash Flow OCF − CapEx | $-45.98M | $10.13M | $15.28M | Not available |
Shares Outstanding | 43.86M | 43.80M | 43.76M | Not available |